Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, Adam L.·2015·Behavioural Brain Research
DOI 10.1016/j.bbr.2014.07.016

Cites (462)

Items 201–400 of 458

  1. Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research
    F.X. Vollenweider · 1998 · Pharmacopsychiatry
  2. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman, Rick J., Qualls, Clifford R., Berg, Laura M. · 1996 · Biological Psychiatry
  3. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’ antipsychotics, clozapine and risperidone
    Rudy Schreiber, Mauricette Brocco, Mark J. Millan · 1994 · European Journal of Pharmacology
  4. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)
    Michael H. Shannon, George Battaglia, Richard A. Glennon, Milt Titeler · 1984 · European Journal of Pharmacology
  5. α1-adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates
    José Manuel Palacios, Daniël Hoyer, Roser Cortés · 1987 · Brain Research
  6. The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs
    Pau Celada, Maria Victoria Puig, Lorenzo Díaz-Mataix, Francesc Artigas · 2008 · Biological Psychiatry
  7. Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.
    Richard E. Belleville, H. F. Fraser, Harris Isbell, C R LOGAN, Abraham Wikler · 1956 · PubMed
  8. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats
    Jennifer L. Scruggs, Dennis E. Schmidt, Ariel Y. Deutch · 2003 · Neuroscience Letters
  9. Agonist activity of LSD and lisuride at cloned 5HT 2A and 5HT 2C receptors
    Christina T. Egan, Katharine Herrick‐Davis, Keith J. Miller, Richard A. Glennon, Milt Teitler · 1998 · Psychopharmacology
  10. Medial Prefrontal Cortex 5-HT2A Density Is Correlated with Amygdala Reactivity, Response Habituation, and Functional Coupling
    Fisher, P. M., Meltzer, C. C., Price, J. C., Coleman, R. L., Ziolko, S. K., Becker, C., Moses-Kolko, E. L., Berga, S. L., Hariri, A. R. · 2009 · Cerebral Cortex
  11. Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage <i>ayahuasca</i> in healthy volunteers
    Riba, Jordi, Anderer, Peter, Morte, Adelaida, Urbano, Gloria, Jané, Francesc, Saletu, Bernd, Barbanoj, Manel J. · 2002 · British Journal of Clinical Pharmacology
  12. Comparison of psilocin with psilocybin, mescaline and LSD-25
    Albert B. Wolbach, Edward J. Miner, Harris Isbell · 1962 · Psychopharmacology
  13. The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine
    J. Christian Gillin, J Kaplan, Richard C. Stillman, Richard Jed Wyatt · 1976 · American Journal of Psychiatry
  14. Interaction of 5-HT2A and 5-HT2C Receptors in R(−)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice
    William Edward Fantegrossi, J. Simoneau, M. S. Cohen, Sarah M. Zimmerman, Curran Henson, Kenner C. Rice, James H. Woods · 2010 · Journal of Pharmacology and Experimental Therapeutics
  15. Selective serotonergic excitation of callosal projection neurons
    Daniel Avesar, Allan T. Gulledge · 2012 · Frontiers in Neural Circuits
  16. Autobiographical memory after temporal lobe resection: neuropsychological and MRI volumetric findings
    Marion Noulhiane, Pascale Piolino, Dominique Hasboun, Stéphane Clémenceau, Michel Baulac, Séverine Samson · 2007 · Brain
  17. Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
    John W. Muschamp, Meredith J. Regina, Elaine M. Hull, Jerrold C. Winter, Richard A. Rabin · 2004 · Brain Research
  18. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
    Robert A. Padich, Timothy C. McCloskey, John H. Kehne · 1996 · Psychopharmacology
  19. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum
    T. E. Sipes, Mark A. Geyer · 1997 · Brain Research
  20. DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors
    T. E. Sipes, Mark A. Geyer · 1995 · Behavioural Pharmacology
  21. 1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2AReceptor Agonists
    Thomas H. McLean, Jason C. Parrish, Michael R. Braden, Danuta Marona‐Lewicka, Alejandra Gallardo‐Godoy, David E. Nichols · 2006 · Journal of Medicinal Chemistry
  22. Electrophysiological evidence for a functional interaction between 5‐HT1A and 5‐HT2A receptors in the rat medial prefrontal cortex: An lontophoretic study
    Charles R. Ashby, Emmeline Edwards, Rex Y. Wang · 1994 · Synapse
  23. EFFECTS OF MESCALINE AND LYSERGIC ACID (d-LSD-25)
    Paul H. Hoch, JAMES P. CATTELL, Harry H. Pennes · 1952 · American Journal of Psychiatry
  24. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
    Clinton Ernest Canal, Uade da Silva, Paul J. Gresch, Erin E. Watt, Elaine Sanders‐Bush, David C. Airey · 2010 · Psychopharmacology
  25. Beyond ego: Transpersonal dimensions in psychology
    ROGER N. WALSH, Frances E. Vaughan · 1980 · Medical Entomology and Zoology
  26. Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
    Steve P. Vickers, Neil Easton, C Malcolm, Nicola H. Allen, R.H Porter, Mike J. Bickerdike, G.A. Kennett · 2001 · Pharmacology Biochemistry and Behavior
  27. Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
    Pablo R. Moya, Kelly A. Berg, M. Gutierrez-Hernandez, Patricio Sáez‐Briones, Miguel Iván Reyes-Parada, Bruce K. Cassels, William P. Clarke · 2007 · Journal of Pharmacology and Experimental Therapeutics
  28. The Role of Kv1.2-Containing Potassium Channels in Serotonin-Induced Glutamate Release from Thalamocortical Terminals in Rat Frontal Cortex
    Evelyn K. Lambe, George K. Aghajanian · 2001 · Journal of Neuroscience
  29. Studies on Lysergic Acid Diethylamide (LSD-25)
    Harris Isbell · 1956 · A M A Archives of Neurology & Psychiatry
  30. Mescal Visions and Eidetic Vision
    Heinrich Klüver · 1926 · The American Journal of Psychology
  31. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
    Adam L. Halberstadt, Mark A. Geyer · 2013 · Neuropharmacology
  32. Quantitative analysis of glutamatergic and GABAergic neurons expressing 5‐HT2A receptors in human and monkey prefrontal cortex
    Julián de Almeida, Guadalupe Mengod · 2007 · Journal of Neurochemistry
  33. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors
    Neil S. Buckholtz, Dongfeng Zhou, Daniel X. Freedman · 1988 · Life Sciences
  34. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide
    Ruth Gross‐Isseroff, Denise Salama, Malka Israeli, Anat R Biegon · 1990 · Brain Research
  35. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli
    Ira D. Hirschhorn, Jerrold C. Winter · 1971 · Psychopharmacology
  36. Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions
    Albert B. Wolbach, Harris Isbell, Edward J. Miner · 1962 · Psychopharmacology
  37. Clinical significance of sleep EEG abnormalities in chronic schizophrenia
    Yang, Changkook, Winkelman, John W. · 2006 · Schizophrenia Research
  38. Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains
    Abdel‐Mouttalib Ouagazzal · 2001 · Neuropsychopharmacology
  39. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists
    Rasmussen, Kurt, Aghajanian, George K. · 1986 · Brain Research
  40. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment
    Josée E. Leysen, Paul F.M. Janssen, Carlos J. E. Niemegeers · 1989 · European Journal of Pharmacology
  41. The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations
    Michael Kometer, B. Rael Cahn, David Andel, Olivia L. Carter, Franz X. Vollenweider · 2010 · Biological Psychiatry
  42. Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs
    Eiichi Jodo, Gary Aston‐Jones · 1997 · Brain Research
  43. The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis
    Meredith A. Fox, Helen T. French, Justin L. LaPorte, Adele R. Blackler, Dennis L. Murphy · 2009 · Psychopharmacology
  44. Stimulation of 5-HT2Receptors in Prefrontal Pyramidal Neurons Inhibits Cav1.2 L-Type Ca2+Currents Via a PLCβ/IP3/Calcineurin Signaling Cascade
    Michelle Day, Patricia A. Olson, Josef Platzer, Jörg Striessnig, Dalton James Surmeier · 2002 · Journal of Neurophysiology
  45. Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala
    Alexander Joseph McDonald, Franco Mascagni · 2007 · Neuroscience
  46. 5HT-2 mediation of acute behavioral effects of hallucinogens in rats
    Lauren L. Wing, Gregory S. Tapson, Mark A. Geyer · 1990 · Psychopharmacology
  47. Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
    Aleksandra Kłodzińska, Maria Bijak, Krzysztof Tokarski, Andrzej Pilc · 2002 · Pharmacology Biochemistry and Behavior
  48. Tolerance and cross-tolerance among psychotomimetic drugs
    James B. Appel, Daniel X. Freedman · 1968 · Psychopharmacology
  49. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats
    Kirsten Krebs-Thomson, Erbert M. Ruiz, Virginia L. Masten, Mahálah R. Buell, Mark A. Geyer · 2006 · Psychopharmacology
  50. Serotoninergic Fine-Tuning of the Excitation–Inhibition Balance in Rat Visual Cortical Networks
    Alexandre William Moreau, Muriel Amar, Nicolas Le Roux, N. Morel, Philippe Fossier · 2009 · Cerebral Cortex
  51. Four factors underlying mouse behavior in an open field
    Shoji Tanaka, Jared W. Young, Adam L. Halberstadt, Virginia L. Masten, Mark A. Geyer · 2012 · Behavioural Brain Research
  52. Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades
    Hannah K. Delille, Judith M. Becker, Sabrina Burkhardt, Barbara Bleher, Georg C. Terstappen, Martin U. Schmidt, Axel H. Meyer, Liliane Unger, Gerard J. Marek, Mario Mezler · 2012 · Neuropharmacology
  53. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells
    Didier Cussac, Elisa A. Boutet-Robinet, Marie‐Christine Ailhaud, Adrian Newman‐Tancredi, Jean‐Claude Martel, Nathalie Danty, Isabelle Rauly‐Lestienne · 2008 · European Journal of Pharmacology
  54. Enriched Expression of Serotonin 1B and 2A Receptor Genes in Macaque Visual Cortex and their Bidirectional Modulatory Effects on Neuronal Responses
    Watakabe, Akiya, Komatsu, Yusuke, Sadakane, Osamu, Shimegi, Satoshi, Takahata, Toru, Higo, Noriyuki, Tochitani, Shiro, Hashikawa, Tsutomu, Naito, Tomoyuki, Osaki, Hironobu et al. · 2009 · Cerebral Cortex
  55. Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem
    Ruth Gross‐Isseroff, Denise Salama, Malka Israeli, Anat R Biegon · 1990 · Brain Research
  56. Flicker-light induced visual phenomena: Frequency dependence and specificity of whole percepts and percept features
    Carsten Allefeld, Peter Pütz, Kristina Kastner, Jiřı́ Wackermann · 2010 · Consciousness and Cognition
  57. Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors
    Eugen Gorea, Joëlle Adrien · 1988 · European Journal of Pharmacology
  58. Parietal Cortex Codes for Egocentric Space beyond the Field of View
    Andreas Schindler, Andreas Bartels · 2012 · Current Biology
  59. Lysergamides of Isomeric 2,4-Dimethylazetidines Map the Binding Orientation of the Diethylamide Moiety in the Potent Hallucinogenic Agent N,N-Diethyllysergamide (LSD)
    David E. Nichols, Stewart P. Frescas, Danuta Marona‐Lewicka, Deborah M. Kurrasch‐Orbaugh · 2002 · Journal of Medicinal Chemistry
  60. Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
    Michael Lyvers, Molly Meester · 2012 · Journal of Psychoactive Drugs
  61. Medial prefrontal cortical innervation of the intercalated nuclear region of the amygdala
    Pinard, C.R., Mascagni, F., McDonald, A.J. · 2012 · Neuroscience
  62. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
    Chad J. Reissig, Lawrence P. Carter, Matthew W. Johnson, Miriam Z. Mintzer, Margaret A. Klinedinst, Roland R. Griffiths · 2012 · Psychopharmacology
  63. Mescal : the ʿdivine' plant and its psychological effects
    Heinrich Klüver, Macdonald Critchley · 1928 · K. Paul, Trench, Trubner eBooks
  64. 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.
    Bryan L. Roth, Esa-Pekka Pälvimäki, S Berry, N Khan, Nancy A. Sachs, Ahmet Uluer, M S Choudhary · 1995 · Journal of Pharmacology and Experimental Therapeutics
  65. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by μ-opiate receptor activation
    Gerard J. Marek, George K. Aghajanian · 1998 · Neuroscience
  66. A comparison of LSD-25 with (?)-?9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC
    Harris Isbell, Donald R. Jasinski · 1969 · Psychopharmacology
  67. Effects of Hallucinogens on Locomotor and Investigatory Activity and Patterns: Influence of 5-HT2A and 5-HT2C Receptors
    Kirsten Krebs-Thomson · 1998 · Neuropsychopharmacology
  68. Potent inhibitory input to locus coeruleus from the nucleus prepositus hypoglossi
    Matthew J. Ennis, Gary Aston‐Jones · 1989 · Brain Research Bulletin
  69. Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)
    Kathryn A. Cunningham, James B. Appel · 1987 · Psychopharmacology
  70. A pre‐ and postsynaptic modulatory action of 5‐HT and the 5‐HT2A, 2C receptor agonist DOB on NMDA‐evoked responses in the rat medial prefrontal cortex
    Viktor L. Arvanov, Xiaofu Liang, Pellegrino Magro, Roy Roberts, Rex Y. Wang · 1999 · European Journal of Neuroscience
  71. Screening hallucinogenic drugs: Systematic study of three behavioral tests
    M. Teresa A. Silva, Helena Maria Calil · 1975 · Psychopharmacology
  72. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    R. L. Smith, Robert J. Barrett, Elaine Sanders‐Bush · 1995 · Journal of Pharmacology and Experimental Therapeutics
  73. Structure–activity relationships of serotonin 5‐HT2Aagonists
    David E. Nichols · 2012 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
  74. Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex
    Zhongwei Zhang, Dany Arsenault · 2005 · The Journal of Physiology
  75. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
    Neil S. Buckholtz, D-F Zhou, Daniel X. Freedman, W Z Potter · 1990 · PubMed
  76. A 5-hydroxytryptamine2 agonist augments γ-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons
    C. Chiang, Gary Aston‐Jones · 1993 · Neuroscience
  77. Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli
    Jerrold C. Winter, Justin R. Eckler, R.A. Rabin · 2004 · Psychopharmacology
  78. The Paradox of 5-Methoxy-N,N-Dimethyltryptamine
    Jerrold C. Winter, Robyn A. Filipink, D. M. Timineri, Scott Helsley, R.A. Rabin · 2000 · Pharmacology Biochemistry and Behavior
  79. Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane
    Efrain E. Garcia, Randy L. Smith, Elaine Sanders‐Bush · 2007 · Neuropharmacology
  80. TEMPORAL DISCRIMINATION AND A FREE‐OPERANT PSYCHOPHYSICAL PROCEDURE
    D. Alan Stubbs · 1980 · Journal of the Experimental Analysis of Behavior
  81. Quantitative autoradiographic mapping of serotonin 5‐HT<sub>1</sub> and 5‐HT<sub>2</sub> receptors and uptake sites in the neocortex of the rhesus monkey
    Lidow, Michael S., Goldman‐Rakic, Patricia S., Gallager, Dorothy W., Rakic, Pasko · 1989 · Journal of Comparative Neurology
  82. Dextromethorphan Abuse
    日浦 渉 · 2004 · Pediatric Emergency Care
  83. Mental changes experimentally produced by L. S. D. (d-Lysergic acid diethylamide tartrate)
    H. Jackson Deshon, Max Rinkel, Harry C. Solomon · 1952 · Psychiatric Quarterly
  84. Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148
    Antonio Balestrieri · 1959 · Archives of General Psychiatry
  85. Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Cortex: Role of Glutamate Spillover and NR2B-NMDA Receptors
    Lambe, Evelyn K, Aghajanian, George K · 2006 · Neuropsychopharmacology
  86. Psilocybin-induced stimulus control in the rat
    Jerrold C. Winter, Kenner C. Rice, D.J. Amorosi, R.A. Rabin · 2007 · Pharmacology Biochemistry and Behavior
  87. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors
    Jonathan C. Gewirtz, Andrew C. H. Chen, Rose Z. Terwilliger, Ronald C Duman, Gerard J. Marek · 2002 · Pharmacology Biochemistry and Behavior
  88. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats
    William Edward Fantegrossi, Andrew W. Harrington, Justin R. Eckler, Sadia Arshad, Richard A. Rabin, Jerrold C. Winter, Andrew Coop, Kenner C. Rice, James Henry Woods · 2005 · Psychopharmacology
  89. Chlordiazepoxide modified exploration in rats
    R. N. Hughes · 1972 · Psychopharmacology
  90. Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures
    Leo E. Hollister, Alan M. Hartman · 1962 · Comprehensive Psychiatry
  91. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives
    David J. Fiorella, R.A. Rabin, Jerrold C. Winter · 1995 · Psychopharmacology
  92. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
    Adam L. Halberstadt, Mark A. Geyer · 2009 · Psychopharmacology
  93. 5-HT2C receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice
    Elizabeth Hackler, David C. Airey, Caitlin C. Shannon, Monsheel Sodhi, Elaine Sanders‐Bush · 2006 · Neuroscience Research
  94. Lysergic Acid Diethylamide (LSD-25): XVII. Tolerance Development and its Relationship to a Theory of Psychosis
    Harold A. Abramson, Murray E. Jarvik, Manuel H. Gorin, M. W. Hirsch · 1956 · The Journal of Psychology
  95. Neuroimaging studies in patients with Charles Bonnet Syndrome
    Hiroaki Kazui, Ryouhei Ishii, Tetsuhiko Yoshida, Koji Ikezawa, Masahiko Takaya, Hiromasa Tokunaga, Toshihisa Tanaka, Masatoshi Takeda · 2009 · Psychogeriatrics
  96. Preliminary fMRI Evidence of Visual System Dysfunction in Parkinson's Disease Patients With Visual Hallucinations
    Suzanne Holroyd, G. Frederick Wooten · 2006 · Journal of Neuropsychiatry
  97. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
    Maurizio S. Riga, Guadalupe Sòria, Raúl Tudela, Francesc Artigas, Pau Celada · 2014 · The International Journal of Neuropsychopharmacology
  98. Clozapine is beneficial for psychosis in Parkinson's disease
    N. Kahn, Alan Freeman, J. L. Juncos, Donald E. Manning, Ray L. Watts · 1991 · Neurology
  99. Group II Metabotropic Glutamate Receptor Modulation of DOI-induced c-fos mRNA and Excitatory Responses in the Cerebral Cortex
    Yan Wei Zhai, Carolyn A. George, Jin Zhai, Eric S. Nisenbaum, Michael P. Johnson, Laura K. Nisenbaum · 2003 · Neuropsychopharmacology
  100. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents
    William Edward Fantegrossi, Chad J. Reissig, E KATZ, Haley L. Yarosh, Kenner C. Rice, J WINTER · 2007 · Pharmacology Biochemistry and Behavior
  101. A Novel (Benzodifuranyl)aminoalkane with Extremely Potent Activity at the 5-HT2A Receptor
    Matthew A. Parker, Danuta Marona‐Lewicka, Virginia L. Lucaites, David L.G. Nelson, David E. Nichols · 1998 · Journal of Medicinal Chemistry
  102. Lack of cross-tolerance in rats among (?) ?9-trans-tetrahydrocannabinol (?9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25)
    M. Teresa A. Silva, E.A. Carlini, U. Claussen, Friedhelm KORTE · 1968 · Psychopharmacology
  103. Discriminative stimulus properties of the serotonergic agent 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
    Richard A. Glennon · 1986 · Life Sciences
  104. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model
    Clinton Ernest Canal, Raymond G. Booth, Drake Morgan · 2013 · Neuropharmacology
  105. Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT 2A receptors are active under physiological conditions
    S. M. Dursun, Sheila L. Handley · 1996 · Psychopharmacology
  106. The two faces of the pharmacological interaction of mGlu2 and 5-HT2A – Relevance of receptor heterocomplexes and interaction through functional brain pathways
    Hannah K. Delille, Mario Mezler, Gerard J. Marek · 2013 · Neuropharmacology
  107. Pharmacological profile of a model for central serotonin receptor activation
    William D. Matthews, Cynthia Daisy Smith · 1980 · Life Sciences
  108. Lysergic Acid Diethylamide (LSD) and Lisuride: Differentiation of Their Neuropharmacological Actions
    Francis J. White, James B. Appel · 1982 · Science
  109. Evidence that 5‐HT2receptor activation decreases noradrenaline release in rat hippocampusin vivo
    Christopher Done, Trevor Sharp · 1992 · British Journal of Pharmacology
  110. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    G. Mocci, L. Jiménez-Sánchez, A. Adell, R. Cortés, F. Artigas · 2014 · Neuropharmacology
  111. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
    Danuta Marona‐Lewicka, David E. Nichols · 2007 · Pharmacology Biochemistry and Behavior
  112. Observations on direct and cross tolerance with LSD and d-amphetamine in man
    D. E. Rosenberg, Albert B. Wolbach, Edward J. Miner, Harris Isbell · 1963 · Psychopharmacology
  113. Differential Ontogenesis of Three DOI-Induced Behaviors in Mice
    Nissar A. Darmani, James H. Shaddy, C Gerdes · 1996 · Physiology & Behavior
  114. Risperidone in levodopa‐induced psychosis in advanced parkinson's disease: An open‐label, long‐term study
    Giuseppe Meco, Andrea Alessandri, Patrizia Giustini, Vincenzo Bonifati · 1997 · Movement Disorders
  115. Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders
    Jacob C. Holzer · 2002 · Psychiatric Services
  116. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex
    Gresch, Paul J, Smith, Randy L, Barrett, Robert J, Sanders-Bush, Elaine · 2005 · Neuropsychopharmacology
  117. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT 2A , but not 5-HT 2C , receptor
    R. L. Smith, Robert J. Barrett, Elaine Sanders‐Bush · 1999 · Psychopharmacology
  118. Characterization of the Discriminative Stimulus Properties Induced by 5‐HT1and 5‐HT2Agonists in Rats
    Jørn Arnt · 1989 · Pharmacology & Toxicology
  119. The 5-HT1A receptor and the stimulus effects of LSD in the rat
    Chad J. Reissig, Justin R. Eckler, R.A. Rabin, Jerrold C. Winter · 2005 · Psychopharmacology
  120. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose
    Páleníček, Tomáš, Balíková, Marie, Bubeníková-Valešová, Věra, Horáček, Jiří · 2008 · Psychopharmacology
  121. Serotonergic regulation of calcium‐activated potassium currents in rodent prefrontal cortex
    Claudio A. Villalobos, Jean-Claude Béïque, Jay A. Gingrich, Rodrigo Andrade · 2005 · European Journal of Neuroscience
  122. Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli
    George K. Aghajanian · 1980 · Brain Research
  123. The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide
    D. E. Rosenberg, Harris Isbell, Edward J. Miner, C. R. Logan · 1964 · Psychopharmacology
  124. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine 1A receptor-mediated behavioral effects overlap its other properties in rats
    Danuta Marona‐Lewicka, Deborah M. Kurrasch‐Orbaugh, Jennifer Selken, Medhane G. Cumbay, Joshua Lisnicchia, David E. Nichols · 2002 · Psychopharmacology
  125. Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin
    Fosco Bernasconi, André Schmidt, Thomas Pokorny, Michael Kometer, Erich Seifritz, Franz X. Vollenweider · 2013 · Cerebral Cortex
  126. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
    Susan M. Mittman, Mark A. Geyer · 1989 · Psychopharmacology
  127. 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens
    Richard A. Rabin, Meredith J. Regina, Mireille Doat, Jerrold C. Winter · 2002 · Pharmacology Biochemistry and Behavior
  128. Clinical Effectiveness of Lisuride Hydrogen Maleate: A Double‐Blind Trial Versus Methysergide
    Werner Martin Herrmann, REINHARD HOROWSKI, K. Dannehl, Uri Kramer, K. Lurati · 1977 · Headache The Journal of Head and Face Pain
  129. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Michelle R. Lofwall, Roland R. Griffiths, Miriam Z. Mintzer · 2006 · Experimental and Clinical Psychopharmacology
  130. A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.
    Lynne M. Adams, Mark A. Geyer · 1985 · Behavioral Neuroscience
  131. Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies.
    Richard A. Glennon, Milt Titeler, Richard Young · 1986 · PubMed
  132. A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.
    Lynne M. Adams, Mark A. Geyer · 1985 · Behavioral Neuroscience
  133. AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes
    Ce Zhang, Gerard J. Marek · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  134. An hallucinogenic amphetamine analog (DOM) in man
    Leo E. Hollister, M. F. Macnicol, H. K. Gillespie · 1969 · Psychopharmacology
  135. Use of 5HT Receptor Agonists and Antagonists for the Characterization of Their Respective Receptor Sites
    Jos�e E. Leysen · 2003 · Humana Press eBooks
  136. Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.
    J. Juncosa, Martin Hansen, L. Bonner, J. Cueva, R. Maglathlin, J. McCorvy, D. Marona-Lewicka, Markus A. Lill, D. E. Nichols · 2013 · ACS Chemical Neuroscience
  137. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens
    Robert A. Lyon, Milt Titeler, Mark R. Seggel, Richard A. Glennon · 1988 · European Journal of Pharmacology
  138. TOLERANCE TO A BEHAVIORAL EFFECT OF LYSERGIC ACID DIETHYLAMIDE AND CROSS-TOLERANCE TO MESCALINE IN THE RAT: ABSENCE OF A METABOLIC COMPONENT
    Jerrold C. Winter · 1971 · Journal of Pharmacology and Experimental Therapeutics
  139. Experimental Psychopathology
    P BRESSER · 1958 · The Medical Journal of Australia
  140. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats
    Kazumasa Yamaguchi, Toshitaka Nabeshima, Kazuhiro Ishikawa, S. Yoshida, Tsutomu Kameyama · 1987 · Neuropharmacology
  141. Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI)
    Joseph G. Wettstein, Martine Host, Janice M. Hitchcock · 1999 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  142. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys
    Nicholson, Katherine L., Hayes, Belinda A., Balster, R. L. · 1999 · Psychopharmacology
  143. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats
    Tomáš Páleníček, Michaela Fujáková, Martin Brunovský, Jiřı́ Horáček, Ingmar Gorman, Marie Balı́ková, Lukáš Rambousek, Kamila Syslová, Petr Kačer, Petr Zach et al. · 2012 · Psychopharmacology
  144. Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys
    Jun‐Xu Li, Kenner C. Rice, Charles Patrick France · 2007 · Journal of Pharmacology and Experimental Therapeutics
  145. Remarks on the Effects of Anhelonium Lewinii (the Mescal Button)
    S. W. Mitchell · 1896 · BMJ
  146. Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist
    Lena Wischhof, Karl J. Hollensteiner, Michael Koch · 2011 · Behavioural Pharmacology
  147. Mescalin and Depersonalization: Therapeutic Experiments
    E. Guttmann, W. S. Maclay · 1936 · Journal of Neurology Neurosurgery & Psychiatry
  148. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats
    V LEHMANNMASTEN, Mark A. Geyer · 1991 · Neuropharmacology
  149. Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex
    Qi Pei, Rosa María Tordera, Marie Sprakes, Trevor Sharp · 2003 · Neuropharmacology
  150. Visual Imagery on Brain Stimulation
    Mardi J. Horowitz · 1968 · Archives of General Psychiatry
  151. Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
    Adam L. Halberstadt, Susan B. Powell, Mark A. Geyer · 2013 · Neuropharmacology
  152. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol
    Susan M. Mittman, Mark A. Geyer · 1991 · Psychopharmacology
  153. Top-Down Spatial Categorization Signal from Prefrontal to Posterior Parietal Cortex in the Primate
    Hugo Merchant, David A. Crowe, Melissa S. Robertson, Marcos Fraga Fortes, Apostolos P. Georgopoulos · 2011 · Frontiers in Systems Neuroscience
  154. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
    Danuta Marona‐Lewicka, Benjamin R. Chemel, David E. Nichols · 2008 · Psychopharmacology
  155. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice
    Randy L. Smith, Robert J. Barrett, Elaine Sanders‐Bush · 2003 · Psychopharmacology
  156. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function
    Katie Ann Jennings, W. John Sheward, Anthony J. Harmar, Trevor Sharp · 2008 · Neuropharmacology
  157. Arylalkylamine Drugs of Abuse
    Richard A. Glennon · 1999 · Pharmacology Biochemistry and Behavior
  158. Sscillatory Cortical Activity during Visual Hallucinations
    Peter Alexander Tass · 1997 · Journal of Biological Physics
  159. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors
    Adam L. Halberstadt, Mahálah R. Buell, Virginia L. Masten, Victoria B. Risbrough, Mark A. Geyer · 2008 · Psychopharmacology
  160. Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36
    Anders Ettrup, Søren Holm, Martin Asser Hansen, Muhammad Wasim, Martin A. Santini, Mikael Palner, Jacob Madsen, Claus Svarer, Jesper Langgaard Kristensen, Gitte M. Knudsen · 2013 · Molecular Imaging and Biology
  161. A PRELIMINARY NOTE ON THE PSYCHIC ACTION OF MESCALIN, WITH SPECIAL REFERENCE TO THE MECHANISM OF VISUAL HALLUCINATIONS
    Alwyn Knauer, William James Maloney · 1913 · The Journal of Nervous and Mental Disease
  162. Abuse Liability Profile of Three Substituted Tryptamines
    Michael B. Gatch, Michael J. Forster, Aaron J. Janowsky, Amy J. Eshleman · 2011 · Journal of Pharmacology and Experimental Therapeutics
  163. The Healing Journey
    Maggie Long, Roger Manktelow, Anne Tracey · 2014 · Qualitative Health Research
  164. Increasing the Selectivity of Drug Discrimination Procedures
    James B. Appel, William B West, Walter G Rolandi, Tevfik ALICI, Kara Pechersky · 1999 · Pharmacology Biochemistry and Behavior
  165. Hallucinogens as a discriminative stimuli: Generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus
    Richard A. Glennon, John A. Rosecrans, Richard Young, Judith Gaines · 1979 · Life Sciences
  166. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice
    John P. Dougherty, V. Aloyo · 2011 · Psychopharmacology
  167. Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT<sub>2A</sub>receptor agonists
    Parrish, Jason C., Braden, Michael R., Gundy, Emily, Nichols, David E. · 2005 · Journal of Neurochemistry
  168. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist
    Gerd D. Bartoszyk, Christoph van Amsterdam, Henning Böttcher, Christoph A. Seyfried · 2003 · European Journal of Pharmacology
  169. Mechanistic studies on DOM as a discriminative stimulus
    Richard A. Glennon, Amy E. Hauck · 1985 · Pharmacology Biochemistry and Behavior
  170. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus
    Jerrold C. Winter, R.A. Rabin · 1988 · Pharmacology Biochemistry and Behavior
  171. Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice
    Bethany R. Brookshire, Sara R. Jones · 2009 · Pharmacology Biochemistry and Behavior
  172. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule
    S. Body, Shirali Kheramin, M.-Y. Ho, Florencio Miranda, C. M. Bradshaw, E. Szabadi · 2003 · Behavioural Pharmacology
  173. COMPARISON OF THREE PSYCHOTROPIC DRUGS (PSILOCYBIN, JB-329, AND IT-290) IN VOLUNTEER SUBJECTS
    Leo E. Hollister, John J. Prusmack, JAMES A. PAULSEN, NORMA ROSENQUIST · 1960 · The Journal of Nervous and Mental Disease
  174. Clinical, biochemical and psychologic effects of psilocybin.
    L E Hollister · 1961 · PubMed
  175. Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs
    Richard A. Glennon · 1991 · PsycEXTRA Dataset
  176. Spontaneous pattern formation and pinning in the primary visual cortex
    Tanya I. Baker, Jack D. Cowan · 2009 · Journal of Physiology-Paris
  177. 5-Hydroxytryptamine (Serotonin)2A Receptors in Rat Anterior Cingulate Cortex Mediate the Discriminative Stimulus Properties of d-Lysergic Acid Diethylamide
    Paul J. Gresch, Robert J. Barrett, Elaine Sanders‐Bush, Randy L. Smith · 2006 · Journal of Pharmacology and Experimental Therapeutics
  178. Serotonin and Schizophrenia
    Boris B. Quednow, Mark A. Geyer, Adam L. Halberstadt · 2010 · Handbook of behavioral neuroscience
  179. Role of atypical opiates in OCD. Experimental approach through the study of 5-HT2A/C receptor-mediated behavior
    M.O. Rojas-Corrales, J. Gibert‐Rahola, Juan Antonio Micó · 2006 · Psychopharmacology
  180. Essential Role for Phosphatidylinositol 4,5-Bisphosphate in the Expression, Regulation, and Gating of the Slow Afterhyperpolarization Current in the Cerebral Cortex
    Claudio A. Villalobos, Robert C. Foehring, Jonathan C. Lee, Rodrigo Andrade · 2011 · Journal of Neuroscience
  181. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice
    Michael A. Benneyworth, Randy L. Smith, Robert J. Barrett, Elaine Sanders‐Bush · 2005 · Psychopharmacology
  182. Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression
    Lena Wischhof, Michael Koch · 2011 · Psychopharmacology
  183. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
    Charlotte Videb�k, Karen Toska, Mark A. Scheideler, Olaf Bjarne Paulson, Gitte M. Knudsen · 2000 · Synapse
  184. Flicker-induced color and form: Interdependencies and relation to stimulation frequency and phase
    Cordula Becker, Mark A. Elliott · 2005 · Consciousness and Cognition
  185. Behavioral evidence for μ-opioid and 5-HT2A receptor interactions
    Gerard J. Marek · 2003 · European Journal of Pharmacology
  186. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    J. B. Appel, Kathryn A. Cunningham · 1986 · PubMed
  187. The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats.
    Kirsten Krebs-Thomson, Mark A. Geyer · 1996 · PubMed
  188. I. In vivo evidence for partial agonist effects of (−)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors
    Maria Lizzie Carlsson, Ethan S. Burstein, Angélica Kloberg, Sarah Hansson, Arja Schedwin, Marie K. L. Nilsson, Johan P. Rung, Arvid Carlsson · 2011 · Journal of Neural Transmission
  189. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity
    Lynne M. Adams, Mark A. Geyer · 1985 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  190. Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex
    Grace E. Stutzmann, Gerard J. Marek, George K. Aghajanian · 2001 · Neuroscience
  191. Dopaminergic and serotonergic mediation of the discriminable effects of Ergot alkaloids
    Alice M. Holohean, Francis J. White, James B. Appel · 1982 · European Journal of Pharmacology
  192. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia
    Maarten van den Buuse, Emma Ruimschotel, Sally Martin, Victoria B. Risbrough, Adam L. Halberstadt · 2011 · Neuropharmacology
  193. Classical Hallucinogens: An Introductory Overview
    Richard A. Glennon · 1994 · PsycEXTRA Dataset
  194. Drugs as Tools in Neurotransmitter Research
    Alan A. Boulton, Glen B. Baker, Augusto V. Juorio · 1989 · Humana Press eBooks
  195. Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice
    Tsuneyuki Yamamoto, Showa Ueki · 1975 · European Journal of Pharmacology
  196. A slow excitatory postsynaptic potential mediated by 5-HT2 receptors in nucleus prepositus hypoglossi
    DH Bobker · 1994 · Journal of Neuroscience
  197. Model Psychoses Induced by LSD-25 in Normals
    Nicholas A. Bercel · 1956 · A M A Archives of Neurology & Psychiatry
  198. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats
    Karim Asgari, S. Body, Victoria K. Bak, Zhongqi Zhang, J. F. Rickard, Jeffrey Colm Glennon, Kevin C.F. Fone, C. M. Bradshaw, E. Szabadi · 2005 · Behavioural Pharmacology
  199. The subjective experience of time during lysergic acid diethylamide (LSD-25) intoxication
    J. C. Kenna, Garry L. Sedman · 1964 · Psychopharmacology
  200. Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: Involvement of the prepositus hypoglossal nucleus
    Eugen Gorea, Damien Davenne, Laurence Lanfumey, Michel Chastanet, Joëlle Adrien · 1991 · Neuropharmacology